FDA advances data, IT modernisation efforts with new Office of Digital Transformation

15 September 2021 - FDA prioritises effective and efficient use of data by reorganising IT, data and cybersecurity functions to ...

Read more →

Professor Gillian Leng to retire from NICE

9 September 2021 - Professor Leng has spent more than 20 years working at NICE. ...

Read more →

Acting FDA Chief Janet Woodcock ruled out as Biden nominee

19 August 2021 - Woodcock faced backlash over controversial Alzheimer’s drug. ...

Read more →

Ellis Unger, an outspoken FDA veteran, retires

12 August 2021 - A top FDA official known for speaking out against controversial drug approval decisions, Ellis Unger, retired ...

Read more →

Biden yet to nominate new FDA chief even as delta surges

8 August 2021 - President Biden has yet to nominate a permanent head of the FDA at a time when ...

Read more →

Biden in standoff with Democratic senators over who should lead FDA

13 July 2021 - Nearly six months into a presidency fully engulfed in a battle against a global pandemic, President Joe ...

Read more →

FDA chief under fire over Alzheimer’s drug decision

22 June 2021 - US regulator’s approval of controversial treatment shows it is too close to Big Pharma, say critics. ...

Read more →

Manchin wants Biden to oust FDA Chief over controversial Alzheimer’s drug approval

17 June 2021 - After some of the FDA’s outside advisors quit in outrage after the agency approved a controversial new ...

Read more →

The FDA is in desperate need of some soul-searching

17 June 2021 - Ordinarily, the approval of a new drug for a dreaded disease affecting millions of Americans would be ...

Read more →

‘A litany of flaws’: advocacy group urges HHS to boot FDA officials over Alzheimer’s drug approval

16 June 2021 - Reacting to the controversial approval of the Biogen Alzheimer’s drug, a leading advocacy group is urging ...

Read more →

The FDA still lacks a permanent chief, despite pressing, weighty problems

12 June 2021 - With the pandemic easing, the federal agency’s long-term agenda for drug approvals or new issues is languishing ...

Read more →

President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals.

25 May 2021 - Within the next few weeks, the FDA is set to make an extraordinary decision: whether or not ...

Read more →

ISPOR announces 2021-2022 Board of Directors

10 May 2021 - Isao Kamae moves into role as President. ...

Read more →

White House expands list of potential FDA Commissioners

14 April 2021 - Asian-American and Black doctors on short list of nominees to lead agency. ...

Read more →

Cavazzoni to take over influential spot atop FDA drug center

12 April 2021 - Patrizia Cavazzoni has been named the permanent leader of the FDA’s Center for Drug Evaluation and ...

Read more →